These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28961942)

  • 61. Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.
    Schneider JG; Wood JB; Schmitt BH; Emery CL; Davis TE; Smith NW; Blevins S; Hiles J; Desai A; Wrin J; Bocian B; Manaloor JJ
    J Antimicrob Chemother; 2019 Jan; 74(Suppl 1):i16-i23. PubMed ID: 30690542
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.
    Marschall J; Agniel D; Fraser VJ; Doherty J; Warren DK
    J Antimicrob Chemother; 2008 Jun; 61(6):1376-83. PubMed ID: 18344548
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy.
    Suppli M; Aabenhus R; Harboe ZB; Andersen LP; Tvede M; Jensen JU
    Clin Microbiol Infect; 2011 Jul; 17(7):1078-83. PubMed ID: 20946408
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli.
    Henig O; Kaye KS; Chandramohan S; Cooper CC; Lephart P; Salimnia H; Taylor M; Pogue JM
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30559141
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimal Antibiotic Duration for Bloodstream Infections Secondary to Intraabdominal Infection.
    Patel K; Maguigan KL; Loftus TJ; Mohr AM; Shoulders BR
    J Surg Res; 2021 Apr; 260():82-87. PubMed ID: 33326932
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.
    Forrest GN; Roghmann MC; Toombs LS; Johnson JK; Weekes E; Lincalis DP; Venezia RA
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3558-63. PubMed ID: 18663022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
    Bookstaver PB; Nimmich EB; Smith TJ; Justo JA; Kohn J; Hammer KL; Troficanto C; Albrecht HA; Al-Hasan MN
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630187
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of a Rapid Blood Culture Diagnostic Test in a Children's Hospital Depends on Gram-Positive versus Gram-Negative Organism and Day versus Night Shift.
    Juttukonda LJ; Katz S; Gillon J; Schmitz J; Banerjee R
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 31852761
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Daptomycin for endocarditis and/or bacteraemia: a systematic review of the experimental and clinical evidence.
    Falagas ME; Giannopoulou KP; Ntziora F; Vardakas KZ
    J Antimicrob Chemother; 2007 Jul; 60(1):7-19. PubMed ID: 17550889
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Development of a treatment algorithm for streptococci and enterococci from positive blood cultures identified with the Verigene Gram-positive blood culture assay.
    Alby K; Daniels LM; Weber DJ; Miller MB
    J Clin Microbiol; 2013 Nov; 51(11):3869-71. PubMed ID: 23985910
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Blood culture Gram stain and clinical categorization based empirical antimicrobial therapy of bloodstream infection.
    Hautala T; Syrjälä H; Lehtinen V; Kauma H; Kauppila J; Kujala P; Pietarinen I; Ylipalosaari P; Koskela M
    Int J Antimicrob Agents; 2005 Apr; 25(4):329-33. PubMed ID: 15784313
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Performance of the Verigene Gram-positive blood culture assay for direct detection of Gram-positive organisms and resistance markers in a pediatric hospital.
    Mestas J; Polanco CM; Felsenstein S; Dien Bard J
    J Clin Microbiol; 2014 Jan; 52(1):283-7. PubMed ID: 24131696
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths by Use of the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay.
    Ledeboer NA; Lopansri BK; Dhiman N; Cavagnolo R; Carroll KC; Granato P; Thomson R; Butler-Wu SM; Berger H; Samuel L; Pancholi P; Swyers L; Hansen GT; Tran NK; Polage CR; Thomson KS; Hanson ND; Winegar R; Buchan BW
    J Clin Microbiol; 2015 Aug; 53(8):2460-72. PubMed ID: 25994165
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Healthcare Improvement Intervention Combining Nucleic Acid Microarray Testing With Direct Physician Response for Management of Staphylococcus aureus Bacteremia.
    Eby JC; Richey MM; Platts-Mills JA; Mathers AJ; Novicoff WM; Cox HL
    Clin Infect Dis; 2018 Jan; 66(1):64-71. PubMed ID: 29020181
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Rapid detection of Gram-positive organisms by use of the Verigene Gram-positive blood culture nucleic acid test and the BacT/Alert Pediatric FAN system in a multicenter pediatric evaluation.
    Sullivan KV; Turner NN; Roundtree SS; Young S; Brock-Haag CA; Lacey D; Abuzaid S; Blecker-Shelly DL; Doern CD
    J Clin Microbiol; 2013 Nov; 51(11):3579-84. PubMed ID: 23966484
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Examining the clinical impact of rapid multiplex polymerase chain reaction-based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration.
    Britt NS; Khader K; He T; Willson TM; Effiong A; Timbrook TT; Potter EM; Lodise TP
    Pharmacotherapy; 2023 Jan; 43(1):24-34. PubMed ID: 36484553
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the nanosphere Verigene BC-GN assay for direct identification of gram-negative bacilli and antibiotic resistance markers from positive blood cultures and potential impact for more-rapid antibiotic interventions.
    Hill JT; Tran KD; Barton KL; Labreche MJ; Sharp SE
    J Clin Microbiol; 2014 Oct; 52(10):3805-7. PubMed ID: 25122857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Rapid molecular determination of methicillin resistance in staphylococcal bacteraemia improves early targeted antibiotic prescribing: a randomized clinical trial.
    Emonet S; Charles PG; Harbarth S; Stewardson AJ; Renzi G; Uckay I; Cherkaoui A; Rougemont M; Schrenzel J
    Clin Microbiol Infect; 2016 Nov; 22(11):946.e9-946.e15. PubMed ID: 27475737
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Utility of the Nanosphere Verigene in the Identification of Bacteremia Isolates From the Burn Intensive Care Unit.
    Farmer A; Lanteri CA; Steele E; Mende K; Pamplin J; Akers KS
    Mil Med; 2017 Sep; 182(9):e1779-e1784. PubMed ID: 28885937
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital.
    Wu CT; Chen CL; Lee HY; Chang CJ; Liu PY; Li CY; Liu MY; Liu CH
    J Microbiol Immunol Infect; 2017 Dec; 50(6):846-856. PubMed ID: 26809591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.